|
KIF1C expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.717000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.359160E-01 |
| Normal-vs-Stage2 |
4.972000E-02 |
| Normal-vs-Stage3 |
8.79759999961038E-07 |
| Normal-vs-Stage4 |
2.24030016759968E-10 |
| Stage1-vs-Stage2 |
1.885220E-01 |
| Stage1-vs-Stage3 |
3.243400E-04 |
| Stage1-vs-Stage4 |
3.64470000000505E-05 |
| Stage2-vs-Stage3 |
1.082830E-01 |
| Stage2-vs-Stage4 |
5.640700E-03 |
| Stage3-vs-Stage4 |
2.508100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.623940E-02 |
| Normal-vs-AfricanAmerican |
3.882000E-03 |
| Normal-vs-Asian |
1.691590E-01 |
| Caucasian-vs-AfricanAmerican |
3.533000E-01 |
| Caucasian-vs-Asian |
2.744200E-01 |
| AfricanAmerican-vs-Asian |
3.701400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.710270E-02 |
| Normal-vs-Female |
8.300200E-03 |
| Male-vs-Female |
2.781600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.436900E-04 |
| Normal-vs-Extreme_Weight |
1.539890E-02 |
| Normal-vs-Obese |
5.740600E-03 |
| Normal-vs-Extreme_Obese |
9.679000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.670400E-02 |
| Normal_Weight-vs-Obese |
1.255170E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.525500E-02 |
| Extreme_Weight-vs-Obese |
7.129200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.119800E-01 |
| Obese-vs-Extreme_Obese |
2.058200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.747960E-01 |
| Normal-vs-Age(41-60Yrs) |
1.070100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.966200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.935500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.136200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.601600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.747000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.059000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.399800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.228190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.943200E-01 |
| Normal-VS-Type2 PRCC |
7.6669000004248E-07 |
| Normal-VS-KIRP CIMP |
1.48840000324668E-08 |
| Normal-VS-Unclassified PRCC |
5.887600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.10160000513326E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.92713999999095E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
5.812800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.130580E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.462500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.846730E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.164960E-04 |
| Normal-vs-N1 |
1.11330000773791E-09 |
| Normal-vs-N2 |
3.69770000000491E-05 |
| N0-vs-N1 |
1.701850E-02 |
| N0-vs-N2 |
1.370770E-01 |
| N1-vs-N2 |
4.161000E-01 |
|
|
